Daejeon, South Korea

Sang Ryeol Shim

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 10.8

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Daejeon-si, KR (2018)
  • Daejeon, KR (2018 - 2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Sang Ryeol Shim: A Pioneer in Cancer Therapeutics

Introduction

Sang Ryeol Shim, an innovative inventor based in Daejeon, South Korea, has made significant contributions to the field of cancer therapeutics. With a remarkable portfolio of five patents, Shim's work focuses primarily on the development of targeted antibodies designed to improve cancer treatment efficacy and patient outcomes.

Latest Patents

Among his latest patents, Shim has developed two groundbreaking innovations. The first is an antibody specifically binding to the epidermal growth factor receptor variant III (EGFRvIII). This patent details a comprehensive approach, including the antibody itself, the nucleic acid coding it, the vector containing the nucleic acid, and a method for producing the antibody. Furthermore, it encompasses a pharmaceutical composition featuring the antibody as an active ingredient aimed at treating various cancers and tumors.

The second patent showcases his work on a dual-target antibody that targets both VEGFR-2 and DLL4. This invention includes not only the novel form of the antibody but also the genes encoding it, recombinant expression vectors, and the host cells transformed with these vectors. The dual-target antibody is positioned to enhance treatment strategies for cancer, further demonstrating Shim's commitment to advancing medical technology.

Career Highlights

Sang Ryeol Shim has had a distinguished career in research and development, working at Pharmabcine Inc. and Pharmabeine Inc. These positions provided him the platform to develop cutting-edge therapies and collaborate with fellow experts in the field.

Collaborations

Throughout his career, Shim has collaborated with several notable colleagues, including Weon Sup Lee and Jin San Yoo. These partnerships have enriched his research endeavors, enabling the integration of diverse insights and expertise to push the boundaries of cancer treatment technologies.

Conclusion

Sang Ryeol Shim stands out as an inventor dedicated to creating innovative solutions in the realm of cancer therapeutics. His patents not only reflect his technical expertise but also embody his passion for improving patient care and outcomes through targeted treatments. With continuing advancements, Shim is poised to make even greater strides in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…